ThermoGenesis Names Dr. Mahendra Rao To Board Of Directors

ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health

ThermoGenesis Corp. Announces Voluntary Recall Of Selected Lots Of AXP Bag Sets

ThermoGenesis Announces New Initiative To Address
Veterinary Regenerative Medicine

ThermoGenesis Corp. To Announce Second Quarter Fiscal 2008 Results On February 6, 2008

ThermoGenesis Corp. Provides Update On Second Fiscal Quarter

ThermoGenesis Corp. To Announce First Quarter Fiscal 2008 Results On November 8, 2007

ThermoGenesis Announces 510(k) Clearance for AutoXpress™ Cord Blood Processing System

ThermoGenesis Corp. To Announce Fourth Quarter & Year End Results For Fiscal Year 2007 On September 12, 2007

ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer And Director

ThermoGenesis Corp. Announces Preliminary Fiscal 2007 Revenues; Company Announces Agreement With Nipro Corporation To Supply AutoXpress™ (AXP™) Platform Disposables

ThermoGenesis Corp. Obtains FDA Clearance To Market Cryoseal® Fibrin Sealant (FS) In Liver Resection Surgeries

Thermogenesis and University of California, Davis Stem Cell Program Collaborate to Develop Stem Cell Treatments for Major Diseases

Thermogenesis Corp. To Announce Third Quarter Fiscal 2007 Results On May 10, 2007

Thermogenesis Corp. To Present At 32nd Annual Deutsche Bank Health Care Conference On Wednesday, May 2, 2007

ThermoGenesis Announces Record Revenues and Key Executive Changes

ThermoGenesis Corp. Granted Three Additional Patents by the U.S. Patent & Trademark Office

ThermoGenesis Announces Higher Production Volumes for AutoXpress™ (AXP™) Cord Blood Stem Cell Processing Bags

ThermoGenesis Corp. Names cell therapy device sales expert Daniel A. Segal as Vice President of Sales & Marketing

Thermogenesis Corp. Submits 510(K) application to FDA for AUTOXPRESS™ Cord Blood Processing System

ThermoGenesis Corp. submits response to FDA on CRYOSEAL® U.S. Pre-Market Approval Application

ThermoGenesis Corp. to announce Second Quarter Fiscal 2007 results on February 9, 2007

ThermoGenesis Corp. to present at International Stem Cells and Regenerative Medicine 2007 meeting

ThermoGenesis Corp. Appoints industry veteran William Osgood as General Manager of Operations

ThermoGenesis Applauds US Department of Health & Human Services' Release of $12 Million in Federal Funds to Qualified US Cord Blood Stem Cell Banks

ThermoGenesis Corp. Granted Broad Patent Protection from European Patent Office for its BioArchive (R) System Cryopreservation and Storage System

ThermoGenesis Corp. Commences Scale-Up of AutoXpress(TM) Production to Meet Demand

ThermoGenesis Presented at FT Global Pharmaceuticals and Biotechnology Conference

ThermoGenesis Corp. to Announce Fourth Quarter & Fiscal Year End Results for Fiscal Year 2006 on September 7, 2006

ThermoGenesis Signs Product Development and Supply Assurance Agreement with Cord Blood Registry (TM)

ThermoGenesis Corp. Signs Agreement with Biomet Biologics, Inc. to Produce Intra-Operative Autologous Fibrin Sealant

ThermoGenesis Expands European Distribution of CryoSeal (R) FS System and Thrombin Processing Device (TM) (TPD) to Czech Republic, Slovakia and Greece

ThermoGenesis Announces Appointment of Dr. Woodrow Myers to Board of Directors

GE Healthcare and New York Blood Center Announce Milestone in Cord Blood Banking

ThermoGenesis & NETCORD Note: U.S. Patent Office's Rejection of PharmStem Cord Blood Stem Cell Patent Claims

New Performance Data Presented at ISCT Demonstrates ThermoGenesis' AutoXpress(TM) System (AXP) Efficiently Separates Stem Cells from Cord Blood

ThermoGenesis Corp. to Announce Third Quarter Results on May 10, 2006

ThermoGenesis Corp. Receives Japanese Patent for BioArchive (R) System

ThermoGenesis Corp. to Present at Deutsche Bank Securities Health Care Conference on Wednesday, May 3, 2006

ThermoGenesis Corp. Receives Health Canada Regulatory License to Market Autologous Thrombin Processing Device(TM) (TPD)

ThermoGenesis Corp. Reports at AMSECT Perfusionist Conference Successful Production of Activated Thrombin from Patient's Whold Blood

ThermoGenesis Expands CryoSeal(R) Fibrin Sealant System and Thrombin Processing Device(TM) (TPD) Distribution in Europe to United Kingdom and Hungary

ThermoGenesis Corp. to Present at SunTrust Robinson Humphrey Institutional Conference on Wednesday, April 12, 2006

ThermoGenesis Corp. Receives Notice of Allowance of Third Patent for Autologous Thrombin Processing Device

Dr. John Chapman Named Vice President of Scientific Affairs

ThermoGenesis' AXP AutoXpress(TM) Platform is Launched by GE Healthcare as the First Automated Functionally Closed Sterile System for the Processing of Cord Blood Stem Cells

ThermoGenesis Expands its CryoSeal (R) FS System Distribution in Europe to Spain, Portugal, Lithuania and Latvia

ThermoGenesis Corp. Closes Offering of Common Stock

ThermoGenesis Receives Health Canada Regulatory License to Market the AutoXpress System (AXP(TM))

ThermoGenesis to Present at Deutsche Bank Small Cap Growth Conference February 15, at 3:00pm ET

ThermoGenesis to Provide Investor Presentation During Second Quarter Results Conference Call on February 8, 2006

ThermoGenesis Corp. Closes Offering of Common Stock

ThermoGenesis Corp. Announces Pricing of Offering of Common Stock

ThermoGenesis Corp. to Announce Second Quarter Results on February 8, 2006

ThermoGenesis Corp. Files PMA to Market CryoSeal (R) Fibrin Sealant (FS) in Liver Resection Surgeries